Literature DB >> 24372139

Ten-year patterns in blood product utilization during cardiothoracic surgery with cardiopulmonary bypass in a tertiary hospital.

Alexander B A Vonk1, Michael I Meesters, Wouter B van Dijk, Leon Eijsman, Johannes W A Romijn, Evert K Jansen, Stephan A Loer, Christa Boer.   

Abstract

BACKGROUND: This retrospective analysis describes blood conservation strategies and overall consumption of red blood cells (RBCs), fresh-frozen plasma (FFP), and platelet (PLT) concentrates during nonaortic cardiac surgery with cardiopulmonary bypass (CPB) in a tertiary hospital over a 10-year period. STUDY DESIGN AND METHODS: Study variables of 6026 patients that underwent cardiac surgery between 2002 and 2011 were incorporated in the database and included hemoglobin (Hb), lowest temperature, CPB duration, 24-hour blood loss, fluid balance, and overall transfusion requirements.
RESULTS: Between 2002 and 2011, the lowest intraoperative Hb levels and temperature increased from 8.5 ± 1.2 to 10.4 ± 1.4 g/dL and from 32 ± 2 to 34 ± 1°C, respectively. In addition to the steep decrease in the postoperative fluid balance over time, a reduction in 24-hour blood loss from 815 ± 588 mL (2002) to 590 ± 438 mL (2011) was observed. These changes were paralleled by a 28% reduction in overall RBC transfusion from 1443 units in 2002 to 1038 in 2011. While RBC transfusion decreased over time, there was no significant change in the use of FFP or PLT concentrate transfusion. The probability to receive RBC transfusion increased after cessation of aprotinin, but reduced after routine cell salvage in all operations.
CONCLUSION: This institutional report shows a large reduction in blood loss and transfusion requirements in cardiac surgery over a 10-year period. This reduction is most probably attributed to structural cell salvage, reduced intraoperative fluid volumes, and the increase in the lowest intraoperative body temperature.
© 2013 AABB.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24372139     DOI: 10.1111/trf.12522

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

Review 1.  Established and potential predictors of blood loss during lung transplant surgery.

Authors:  Pascal Oechslin; Marco P Zalunardo; Ilhan Inci; Martin Schlaepfer; Bastian Grande
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.

Authors:  Marco Ranucci; Ekaterina Baryshnikova; Giulia Beatrice Crapelli; Niels Rahe-Meyer; Lorenzo Menicanti; Alessandro Frigiola
Journal:  J Am Heart Assoc       Date:  2015-06-02       Impact factor: 5.501

3.  Benchmarking the use of blood products in cardiac surgery to stimulate awareness of transfusion behaviour : Results from a four-year longitudinal study.

Authors:  C Brouwers; B Hooftman; S Vonk; A Vonk; W Stooker; W H Te Gussinklo; R M Wesselink; C Wagner; M C de Bruijne
Journal:  Neth Heart J       Date:  2017-03       Impact factor: 2.380

Review 4.  Leukodepleted Packed Red Blood Cells Transfusion in Patients Undergoing Major Cardiovascular Surgical Procedure: Systematic Review and Meta-Analysis.

Authors:  Daniel Simancas-Racines; Ingrid Arevalo-Rodriguez; Gerard Urrutia; Diana Buitrago-Garcia; Solange Núñez-González; María José Martínez-Zapata; Eva Madrid; Xavier Bonfill; Ricardo Hidalgo-Ottolenghi
Journal:  Cardiol Res Pract       Date:  2019-02-25       Impact factor: 1.866

5.  The effect of non-point-of-care haemostasis management protocol implementation in cardiac surgery: A systematic review.

Authors:  Reinier P J Boxma; Robert P Garnier; Carolien S E Bulte; Michael I Meesters
Journal:  Transfus Med       Date:  2021-06-06       Impact factor: 2.019

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.